UNIVERSITY OF WASHINGTON
WORCESTER, Washington
Total Received
$3.96B
Total Awards
499
State
Washington
Last Updated
Mar 20, 2026
Yearly Funding Trend
$3.73B24
$195.2M25
$29.0M26
Top 50 Awards to UNIVERSITY OF WASHINGTON
Largest individual federal awards on record for this recipient, ranked by obligated amount. Data through March 20, 2026.
| Award | Awarding Agency | Program | Place | FY | Obligation |
|---|---|---|---|---|---|
ASST_NON_UM1AI068614_075 HIV VACCINES CLINICAL TRIALS NETWORK LEADERSHIP AND OPERATIONS CENTER - THIS PROPOSAL OUTLINES THE SCIENTIFIC AGENDA OF THE LEADERSHIP AND OPERATIONS CENTER OF THE HIV VACCINE TRI… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | SEATTLE, WA-07 | 2024 | $1,062,954,652 |
ASST_NON_UM1AI068618_075 HVTN 405/HPTN 1901 (COVPN) CHARACTERIZING SARS-COV-2-SPECIFIC IMMUNITY IN CONVALESCENT INDIVIDUALS - ABSTRACT: WITH THE RAPID ONSET OF THE COVID-19 PANDEMIC, WE RECOGNIZE THERE IS… | Department of Health and Human Services National Institutes of Health | 93.121 ORAL DISEASES AND DISORDERS RESEARCH | SEATTLE, WA-07 | 2024 | $429,366,473 |
ASST_NON_UM1AI068635_075 SDMC: HIV VACCINE TRIALS NETWORK - PROJECT SUMMARY/ABSTRACT THIS APPLICATION PROPOSES TO CONTINUE AS THE STATISTICAL AND DATA MANAGEMENT CENTER (SDMC) FOR THE HIV VACCINE TRIALS N… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | SEATTLE, WA-07 | 2024 | $368,129,707 |
ASST_NON_P30CA015704_075 CANCER CENTER SUPPORT GRANT - THE MISSION OF THE FRED HUTCH/UNIVERSITY OF WASHINGTON/SEATTLE CHILDREN’S CANCER CONSORTIUM IS TO UNITE INNOVATIVE RESEARCH AND COMPASSIONATE CARE TO… | Department of Health and Human Services National Institutes of Health | 93.397 CANCER CENTERS SUPPORT GRANTS | WA-90 | 2024 | $210,648,769 |
ASST_NON_UM1AI068617_075 SDMC: HIV PREVENTION TRIALS NETWORK - PROJECT SUMMARY/ABSTRACT THIS APPLICATION TO RFA-AI-19-002 IS TO CONTINUE AS THE STATISTICAL AND DATA MANAGEMENT CENTER (SDMC) FOR THE HIV PR… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | SEATTLE, WA-07 | 2024 | $195,693,448 |
ASST_NON_U10CA180819_075 SWOG STATISTICS & DATA MANAGEMENT CENTER COMPLEX - EXTENSION SUPPLEMENT FOR GY06 - PROJECT SUMMARY/ABSTRACT OVERALL COMPONENT THE SWOG STATISTICS AND DATA MANAGEMENT CENTER (SDMC)… | Department of Health and Human Services National Institutes of Health | 93.395 CANCER TREATMENT RESEARCH | SEATTLE, WA-07 | 2024 | $96,205,648 |
ASST_NON_P01CA018029_075 ADULT LEUKEMIA RESEARCH CENTER - PROJECT SUMMARY/ABSTRACT OVERALL ACUTE MYELOID LEUKEMIA (AML) AND MULTIPLE MYELOMA (MM) ARE DISEASES OF THE ELDERLY, WITH MEDIAN INCIDENCE OF DISE… | Department of Health and Human Services National Institutes of Health | 93.395 CANCER TREATMENT RESEARCH | WA-90 | 2024 | $69,669,587 |
ASST_NON_U24CA086368_075 THE EARLY DETECTION RESEARCH NETWORK: DATA MANAGEMENT AND COORDINATING CENTER - PROJECT SUMMARY THE KEY FOR THE EARLY DETECTION RESEARCH NETWORK (EDRN)'S SUCCESS LIES IN GOOD COMM… | Department of Health and Human Services National Institutes of Health | 93.394 CANCER DETECTION AND DIAGNOSIS RESEARCH | SEATTLE, WA-07 | 2024 | $67,679,289 |
CONT_AWD_75N92021F00001_7529_75N92021D00001_7529 THE PURPOSE OF THIS MODIFICATION IS TO EXERCISE OPTION PERIOD 4 | Department of Health and Human Services National Institutes of Health | — | SEATTLE, WA-07 | 2024 | $47,116,620 |
ASST_NON_P50CA097186_075 THE PACIFIC NORTHWEST PROSTATE CANCER SPORE - PROJECT SUMMARY/ABSTRACT THE PACIFIC NORTHWEST (PNW) PROSTATE CANCER SPORE CONTINUATION GRANT REPRESENTS A COORDINATED EFFORT OF FOUR… | Department of Health and Human Services National Institutes of Health | 93.397 CANCER CENTERS SUPPORT GRANTS | SEATTLE, WA-07 | 2024 | $38,742,250 |
CONT_AWD_75N91020C00005_7529_-NONE-_-NONE- THE CONTRACTOR SHALL OPERATE THE NATIONAL CANCER INSTITUTE'S CONTACT CENTER TO HANDLE INQUIRIES ON BEHALF OF NCI. THE CONTRACTOR SHALL PROVIDE SCIENTIFICALLY BASED, UNBIASED INFOR… | Department of Health and Human Services National Institutes of Health | — | SEATTLE, WA-07 | 2024 | $36,724,235 |
CONT_AWD_75N91018F00001_7529_75N91018D00004_7529 CORE INFRASTRUCTURE SUPPORT FOR SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) | Department of Health and Human Services National Institutes of Health | — | SEATTLE, WA-07 | 2024 | $35,250,370 |
ASST_NON_P01CA078902_075 PREVENTING RELAPSE AFTER NON-MYELOABLATIVE STEM CELL TRANSPLANTATION: THE FINAL CHALLENGE - PROJECT SUMMARY / ABSTRACT - OVERALL THE OVERALL GOAL OF THIS PROGRAM PROJECT GRANT IS… | Department of Health and Human Services National Institutes of Health | 93.395 CANCER TREATMENT RESEARCH | SEATTLE, WA-07 | 2024 | $31,545,191 |
ASST_NON_UM1AI069481_075 SEATTLE CLINICAL TRIALS UNIT - THE SEATTLE-LAUSANNE CLINICAL TRIALS UNIT (CTU) HAS A COMMON VISION TO LIVE IN A WORLD WITHOUT NEW HIV INFECTIONS AND FREE OF AIDS-RELATED MORBIDITY… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | SEATTLE, WA-07 | 2024 | $23,611,215 |
ASST_NON_U54CA132381_075 2/2 PARTNERSHIP FOR THE ADVANCEMENT OF CANCER RESEARCH: NMSU & FRED HUTCH - THE PARTNERSHIP BETWEEN NMSU, A LAND-GRANT UNIVERSITY, AND FRED HUTCH, A COMPREHENSIVE CANCER CENTER, H… | Department of Health and Human Services National Institutes of Health | 93.397 CANCER CENTERS SUPPORT GRANTS | SEATTLE, WA-07 | 2024 | $21,179,049 |
ASST_NON_UM1CA154967_075 CANCER IMMUNOTHERAPY TRIALS NETWORK CENTRAL OPERATIONS AND STATISTICAL CENTER - PROJECT SUMMARY THE CANCER IMMUNOTHERAPY TRIALS NETWORK (CITN) CAME ABOUT FROM DISCUSSIONS AT THE 2… | Department of Health and Human Services National Institutes of Health | 93.395 CANCER TREATMENT RESEARCH | WA-90 | 2025 | $20,745,202 |
ASST_NON_U24HL169645_075 MOSAAIC COGNITIVE ASSESSMENT READING CENTER ADMINISTRATIVE SUPPLEMENT - PROJECT SUMMARY THE MULTIETHNIC OBSERVATIONAL STUDY IN AMERICAN ASIAN AND PACIFIC ISLANDER COMMUNITIES (MOS… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | WA-90 | 2024 | $18,523,030 |
ASST_NON_U01AI069197_075 HEMATOPOIETIC STEM CELL AND CORD BLOOD TRANSPLANTATION - PROJECT SUMMARY/ABSTRACT HEMATOPOIETIC CELL TRANSPLANTATION FROM UNRELATED DONORS, HAPLOIDENTICAL RELATED DONORS AND CORD… | Department of Health and Human Services National Institutes of Health | 93.393 CANCER CAUSE AND PREVENTION RESEARCH | WA-90 | 2024 | $15,858,841 |
ASST_NON_P50CA228944_075 FRED HUTCHINSON CANCER RESEARCH CENTER LUNG SPORE - PROJECT SUMMARY/ABSTRACT – OVERALL THE FRED HUTCH LUNG SPORE CONSISTS OF FOUR INNOVATIVE PROJECTS, THREE SUPPORTIVE CORES, AND… | Department of Health and Human Services National Institutes of Health | 93.397 CANCER CENTERS SUPPORT GRANTS | WA-90 | 2024 | $14,811,581 |
ASST_NON_U01CA152637_075 FRED HUTCHINSON BREAST CANCER CLINICAL VALIDATION CENTER - ABSTRACT THERE REMAIN CLEAR CLINICAL AND PUBLIC HEALTH NEEDS TO IMPROVE THE EARLY DETECTION OF BREAST CANCER. WHILE MAMM… | Department of Health and Human Services National Institutes of Health | 93.394 CANCER DETECTION AND DIAGNOSIS RESEARCH | SEATTLE, WA-07 | 2024 | $13,581,230 |
ASST_NON_R01CA119171_075 NUTRITION AND PHYSICAL ACTIVITY ASSESSMENT STUDY (NPAAS) - PROJECT SUMMARY THIS COMPETING RENEWAL OF CA119171-17 “NUTRITION AND PHYSICAL ACTIVITY ASSESSMENT STUDY” (NPAAS) CONTINU… | Department of Health and Human Services National Institutes of Health | 93.393 CANCER CAUSE AND PREVENTION RESEARCH | WA-90 | 2024 | $11,802,814 |
CONT_AWD_75N92026F00001_7529_75N92021D00001_7529 WOMEN'S HEALTH INITIATIVE (WHI) CLINICAL COORDINATING CENTER - TASK AREA A AND A2 | Department of Health and Human Services National Institutes of Health | — | SEATTLE, WA-07 | 2026 | $10,225,386 |
ASST_NON_U54CA242977_075 COLABORACION EVITA: HPV-RELATED CANCER PREVENTION PARTNERSHIP CENTER - PROJECT SUMMARY – OVERALL WORLDWIDE, CERVICAL CANCER IS THE FOURTH LEADING CAUSE OF CANCER INCIDENCE AND MOR… | Department of Health and Human Services National Institutes of Health | 93.399 CANCER CONTROL | WA-90 | 2024 | $10,161,598 |
ASST_NON_R01HL151152_075 POLYGENIC RISK SCORES FOR DIVERSE POPULATIONS - BRIDGING RESEARCH AND CLINICAL CARE - ABSTRACT CARDIOVASCULAR DISEASE (CVD) AND ITS RISK FACTORS IMPOSE MAJOR SOCIETAL BURDENS AND… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | WA-90 | 2024 | $10,051,303 |
ASST_NON_K12CA076930_075 CAREER DEVELOPMENT IN PEDIATRIC AND MEDICAL ONCOLOGY - PROJECT SUMMARY/ABSTRACT WE ARE REQUESTING FUNDS FOR THE PAUL CALABRESI CAREER DEVELOPMENT AWARD FOR CLINICAL ONCOLOGY IN PE… | Department of Health and Human Services National Institutes of Health | 93.395 CANCER TREATMENT RESEARCH | SEATTLE, WA-07 | 2024 | $9,856,670 |
ASST_NON_UH3HL147011_075 1/2 GANCICLOVIR TO PREVENT REACTIVATION OF CYTOMEGALOVIRUS IN PATIENTS WITH ACUTE RESPIRATORY FAILURE AND SEPSIS - PROJECT SUMMARY SEPSIS-ASSOCIATED ACUTE RESPIRATORY FAILURE IS A… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | WA-90 | 2024 | $9,788,465 |
ASST_NON_R01CA201407_075 USING FUNCTIONAL GENOMICS TO INFORM GENE ENVIRONMENT INTERACTIONS FOR COLORECTAL CANCER - PROJECT SUMMARY/ABSTRACT COLORECTAL CANCER (CRC) IS A COMPLEX DISEASE WITH BOTH GENETIC (… | Department of Health and Human Services National Institutes of Health | 93.393 CANCER CAUSE AND PREVENTION RESEARCH | SEATTLE, WA-07 | 2024 | $9,586,624 |
ASST_NON_R35GM118120_075 MOLECULAR ANALYSIS OF GENETIC RECOMBINATION AND DNA BREAK REPAIR - PROJECT SUMMARY/ABSTRACT THE LONG-TERM GOAL OF THE RESEARCH PROPOSED HERE IS TO DETERMINE THE MOLECULAR MECHANIS… | Department of Health and Human Services National Institutes of Health | 93.859 BIOMEDICAL RESEARCH AND RESEARCH TRAINING | WA-90 | 2024 | $9,302,975 |
ASST_NON_P01AI138212_075 EXPANSION AND TARGETED MATURATION OF GERMLINE HIV-1 BNAB-ASSOCIATED BCRS - ABSTRACT THE ELICITATION OF POTENT AND BROAD HIV-1 NEUTRALIZING ANTIBODIES (BNABS) BY IMMUNIZATION HAS B… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | WA-90 | 2025 | $9,201,872 |
ASST_NON_R01CA118953_075 IMPROVING OUTCOMES ASSESSMENT IN CHRONIC GRAFT VERSUS HOST DISEASE - PROJECT SUMMARY ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION (HCT) CAN CURE MANY HEMATOLOGIC CANCERS AND OTHE… | Department of Health and Human Services National Institutes of Health | 93.395 CANCER TREATMENT RESEARCH | SEATTLE, WA-07 | 2024 | $9,074,792 |
ASST_NON_R01AI076105_075 THE ROLE OF ANTIBODIES IN MOTHER TO CHILD HIV TRANSMISSION - ABSTRACT: IN ORDER TO HARNESS THE POTENTIAL OF THE HIV-SPECIFIC ANTIBODY RESPONSE FOR PREVENTION, IT IS IMPORTANT TO D… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | SEATTLE, WA-07 | 2025 | $8,756,493 |
CONT_AWD_75N91025C00008_7529_-NONE-_-NONE- THE NATIONAL CANCER INSTITUTE'S (NCI) CANCER INFORMATION SERVICE (CIS) IS AN EXISTING AND ESTABLISHED CRITICAL COMPONENT OF HEALTHCARE DELIVERY, PARTICULARLY IN FACILITATING PUBLI… | Department of Health and Human Services National Institutes of Health | — | SEATTLE, WA-07 | 2025 | $8,675,788 |
ASST_NON_UG1CA286954_075 NCI CANCER SCREENING RESEARCH NETWORK: COORDINATING AND COMMUNICATION CENTER - THE PROMISE OF EARLY DETECTION TO REDUCE THE BURDEN OF CANCER IS AN EASILY UNDERSTOOD AND HIGHLY DES… | Department of Health and Human Services National Institutes of Health | 93.399 CANCER CONTROL | SEATTLE, WA-07 | 2024 | $8,584,810 |
ASST_NON_U01CA214114_075 PROTEOGENOMIC STUDIES AIMED AT UNDERSTANDING OVARIAN TUMOR RESPONSES TO AGENTS TARGETING THE DNA DAMAGE RESPONSE AND TRANSLATING THIS KNOWLEDGE INTO CLINICAL BENEFIT - PROJECT SUM… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | SEATTLE, WA-07 | 2024 | $8,301,359 |
ASST_NON_U54DK106829_075 STEM CELL AND TRANSPLANTATION BIOLOGY - PROJECT SUMMARY/ABSTRACT - OVERALL THE THEME OF THIS CCEH IS FOCUSED ON STEM CELL AND TRANSPLANTATION BIOLOGY. THE AIMS ARE DESIGNED TO OVE… | Department of Health and Human Services National Institutes of Health | 93.847 DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH | SEATTLE, WA-07 | 2024 | $8,263,211 |
ASST_NON_U19AI174242_075 SELF-AMPLIFYING MRNA-BASED VACCINES TO ELICIT VRC01-CLASS BNABS - ABSTRACT OVERALL THE MAIN GOAL OF OUR IPCAVD PROGRAM GRANT IS TO EVALUATE IN HUMANS SELF-AMPLIFYING MRNA (SARNA)… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | SEATTLE, WA-07 | 2024 | $8,239,305 |
ASST_NON_C06OD039902_075 UPGRADING INSTITUTIONAL CAPACITY WITH A BSL-3 FACILITY FOR MULTIDISCIPLINARY BIOMEDICAL RESEARCH - PROJECT SUMMARY/ABSTRACT: THE FRED HUTCHINSON CANCER CENTER (FRED HUTCH) PROPOSE… | Department of Health and Human Services National Institutes of Health | 93.352 CONSTRUCTION SUPPORT | SEATTLE, WA-07 | 2025 | $7,947,160 |
ASST_NON_U54CA274374_075 UNDERSTANDING ADENOMA PROGRESSION: INTERPLAY AMONG TISSUE MICROENVIRONMENT, CLONAL ARCHITECTURE, AND GUT MICROBIOME - SUMMARY COLORECTAL CANCER (CRC) AFFECTS ~145,000 PEOPLE/YEAR… | Department of Health and Human Services National Institutes of Health | 93.399 CANCER CONTROL | WA-90 | 2024 | $7,696,898 |
ASST_NON_R33HL151885_075 PHYSICAL ACTIVITY TO IMPROVE CV HEALTH IN OLDER WOMEN: A PRAGMATIC TRIAL - THIS IS A COMPETITIVE RENEWAL APPLICATION FOR THE WOMEN’S HEALTH INITIATIVE (WHI) STRONG & HEALTHY (WHIS… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | SEATTLE, WA-07 | 2024 | $7,589,270 |
ASST_NON_U01CA173642_075 LIFE AND LONGEVITY AFTER CANCER (LILAC): THE WOMEN'S HEALTH INITIATIVE CANCER SURVIVOR COHORT - SUMMARY/ABSTRACT THERE ARE 16 MILLION CANCER SURVIVORS IN THE UNITED STATES, AND AP… | Department of Health and Human Services National Institutes of Health | 93.393 CANCER CAUSE AND PREVENTION RESEARCH | WA-90 | 2024 | $7,510,704 |
ASST_NON_R01AI054423_075 GENETIC REQUIREMENTS OF HELICOBACTER PYLORI INFECTION - PROJECT SUMMARY HELICOBACTER PYLORI CHRONICALLY INFECTS THE HUMAN STOMACH OF HALF THE WORLD AND APPROXIMATELY A THIRD OF TH… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | WA-90 | 2024 | $7,433,157 |
ASST_NON_R01CA100019_075 CLINICAL SIGNIFICANCE OF MHC HAPLOTYPES IN HCT - PROJECT SUMMARY THE HLA SYSTEM ENCODED ON CHR6P DEFINES THE HEMATOPOIETIC-CELL TRANSPLANTATION BARRIER. COMPLETE AND PRECISE HLA A… | Department of Health and Human Services National Institutes of Health | 93.395 CANCER TREATMENT RESEARCH | WA-90 | 2024 | $7,407,006 |
ASST_NON_R01HL128239_075 GENETIC AND MOLECULAR BASIS FOR SRSF2 MUTATIONS IN MYELODYSPLASIA - SUMMARY MUTATIONS IN GENES ENCODING RNA SPLICING FACTORS ARE THE MOST COMMON CLASS OF GENETIC ALTERATIONS IN MY… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | WA-90 | 2025 | $7,203,851 |
ASST_NON_R01CA114536_075 NOVEL SYNTHETIC RECEPTORS WITH IMPROVED ANTIGEN SPECIFICITY AND SPECIFICITY FOR CANCER THERAPY - ABSTRACT ADOPTIVE CELL THERAPY USING T CELLS MODIFIED BY GENE TRANSFER TO EXPRESS… | Department of Health and Human Services National Institutes of Health | 93.395 CANCER TREATMENT RESEARCH | SEATTLE, WA-07 | 2024 | $7,167,964 |
ASST_NON_R01AR045203_075 D4Z4 CODING TRANSCRIPTS AND FSHD - PROJECT SUMMARY FACIOSCAPULOHUMERAL DYSTROPHY (FSHD) IS CAUSED BY THE MIS-EXPRESSION OF THE EMBRYONIC TRANSCRIPTION FACTOR DUX4 IN SKELETAL MUSC… | Department of Health and Human Services National Institutes of Health | 93.846 ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH | WA-90 | 2024 | $7,131,390 |
ASST_NON_R01CA206464_075 MOLECULAR PATHOEPIDEMIOLOGY OF CONTRALATERAL BREAST CANCER - ABSTRACT SURVIVORS OF FIRST PRIMARY BREAST CANCER (BC) HAVE A 2- TO 5-FOLD INCREASED RISK OF DEVELOPING A SECOND PRIMA… | Department of Health and Human Services National Institutes of Health | 93.393 CANCER CAUSE AND PREVENTION RESEARCH | WA-90 | 2024 | $7,005,169 |
ASST_NON_R01HL136135_075 MULTIPLEX BASE/PRIME EDITORS FOR IN VIVO SELECTION OF MODIFIED HSPCS IN HEMOGLOBINOPATHY - A SIGNIFICANT OBSTACLE IN CURRENT HEMATOPOIETIC STEM CELL (HSC) GENE THERAPY STUDIES HAS… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | SEATTLE, WA-07 | 2024 | $6,753,937 |
ASST_NON_R35CA197222_075 TARGETING NRF2 FOR CANCER CHEMOPREVENTION - DESCRIPTION (PROVIDED BY APPLICANT): ENVIRONMENTAL CARCINOGENS AND OTHER TOXICANTS CONTRIBUTE TO THE INCREASING BURDEN OF CANCER A… | Department of Health and Human Services National Institutes of Health | 93.393 CANCER CAUSE AND PREVENTION RESEARCH | SEATTLE, WA-07 | 2024 | $6,669,482 |
ASST_NON_U01CA224255_075 PROSTATE CANCER ACTIVE SURVEILLANCE STUDY (PASS) COHORT: INFRASTRUCTURE SUPPORT FOR CANCER RESEARCH - PROJECT SUMMARY/ABSTRACT WE PROPOSE TO SUPPORT THE ESTABLISHED PROSTATE CANCE… | Department of Health and Human Services National Institutes of Health | 93.394 CANCER DETECTION AND DIAGNOSIS RESEARCH | WA-90 | 2024 | $6,664,439 |
ASST_NON_R35GM140823_075 MECHANISMS OF TRANSCRIPTIONAL REGULATION AND TRANSCRIPTION FACTOR SPECIFICITY - SUMMARY THE SUBSET OF TRANSCRIPTION FACTORS (TFS) EXPRESSED IN A EUKARYOTIC CELL DETERMINES MANY OF… | Department of Health and Human Services National Institutes of Health | 93.859 BIOMEDICAL RESEARCH AND RESEARCH TRAINING | SEATTLE, WA-07 | 2024 | $6,609,003 |
Top 50 awards shown, ranked by obligated amount. Dates reflect performance period; last-modified dates match USAspending.gov. Complete listings include all transaction history going back to FY2024.
Industries
View All→123456
RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)$101.1M
TELEMARKETING BUREAUS AND OTHER CONTACT CENTERS$45.4M
RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY)$5.6M
TESTING LABORATORIES AND SERVICES$387K
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)$377K
ALL OTHER PROFESSIONAL, SCIENTIFIC, AND TECHNICAL SERVICES$105K
Federal Programs (CFDA)
View All→12345678910
93.855 — ALLERGY AND INFECTIOUS DISEASES RESEARCH$1.83B
93.121 — ORAL DISEASES AND DISORDERS RESEARCH$434.9M
93.395 — CANCER TREATMENT RESEARCH$359.0M
93.397 — CANCER CENTERS SUPPORT GRANTS$290.4M
93.393 — CANCER CAUSE AND PREVENTION RESEARCH$167.3M
93.394 — CANCER DETECTION AND DIAGNOSIS RESEARCH$163.4M
93.837 — CARDIOVASCULAR DISEASES RESEARCH$119.1M
93.859 — BIOMEDICAL RESEARCH AND RESEARCH TRAINING$102.5M
93.396 — CANCER BIOLOGY RESEARCH$67.1M
93.399 — CANCER CONTROL$34.7M
Source: USAspending.gov · All Recipients · Washington